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Abstract: Nanoscale three-dimensional (3D) scaffolds offer great promise for improved 
tissue integration and regeneration by their physical and chemical property enhancements. 
Electrospinning is a versatile bottom-up technique for producing porous 3D nanofibrous 
scaffolds that could closely mimic the structure of extracellular matrix. Much work has 
been committed to the development of this process through the years, and the resultant 
nanostructures have been subjugated to a wide range of applications in the field of 
bioengineering. In particular, the application of ceramic nanofibres in hard tissue 
engineering, such as dental and bone regeneration, is of increased research interest. This 
mini-review provides a brief overview of the bioceramic nanofibre scaffolds fabricated by 
electrospinning and highlights some of the significant process developments over recent 
years with their probable future trends and potential applications as biomedical implants. 
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1. Introduction 
Ceramic materials employed within the body are generally termed bioceramics, which fall into the 
classifications of being bioinert, bioresorbable and bioactive based on the properties of remaining 
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unchanged, dissolving or actively taking part in a physiological process. Materials classified as 
bioceramics include alumina, zirconia, calcium phosphates, titania, silica-based glasses or glass 
ceramics and pyrolytic carbons [1]. Various forms of bioceramics have been fabricated based on the 
need and applications, comprised of microspheres, thin layer coating on implants, porous networks, 
composites with a polymer component and large well-polished surfaces [2]. The properties of solids 
are altered with great reductions in particle size ranging to the scale of nanometres, which does not 
easily come into play when going from macro- to micro-dimensions. Ceramic structures at the 
nanometre range have been proven to have improved properties and characteristics that differ from 
their bulk, allowing for opportunities in novel technological applications [3]. Top-down and bottom-up 
approaches are the two major routes to obtain ceramic nanostructures. Ceramic nanofibres, having 
advantages, including a very high surface-to-volume and aspect ratio, over other forms, can be 
processed by a number of techniques, including template-assisted synthesis [4], self-assembly [5]  
and electrospinning [6]. 
Electrospinning is a versatile bottom-up technique that was introduced in the early 1930s [7]. It has 
gained increased interest since 2000 for its continuous one-dimensional nanofibre production 
possibility. During the past decade, a large number of research activities involving electrospinning 
increased, leading to the development of mass-production, innovative compositions and a large variety 
of applications spanning many industrial sectors [8]. However, electrospinning of ceramic nanofibres, 
especially bioceramics, offers challenges to the process and control of the orientation. This paper 
reviews significant reports on the electrospinning of various bioceramic nanofibres, research 
developments and their potential applications in the biomedical field. 
2. Electrospinning Bioceramic Nanofibres 
For electrospun ceramic nanofibrous scaffolds in biomedical applications, the biological properties, 
such as biocompatibility, biodegradability and specific cell interactions, are largely determined by the 
materials’ properties and nature. Electrospun scaffolds can be tailored with desired new functions by 
selecting a suitable material or composite and by adjusting the component ratio, fibre diameter and 
morphology through process parameters. In the process of electrospinning, a high electrostatic voltage 
is imposed on a drop of solution held by its surface tension at the end of a capillary, leading to 
distortion of the liquid into a conical jet (known as the Taylor cone), ejecting fibres [9,10]. Once the 
voltage exceeds a critical value, the electrostatic force overcomes the solution surface tension, and a 
stable liquid jet is ejected from the cone tip. The solvent evaporates as the jet travels through the air, 
leaving behind ultra-fine fibres with a high surface-to-volume ratio collected on an  
electrically-grounded target [11,12]. 
With two types of electrospinning, namely melt spinning and wet spinning, being practiced, the 
latter is the most commonly used. In melt spinning, the material is melted by applying external heat to 
form a melt to spin, whereas in wet spinning, the component is dissolved in a suitable solvent to form a 
spinnable solution, which is then subjected to high electrostatic voltage [13,14]. As ceramics have a 
high melting point, they are mostly electrospun by the wet method as a sol-gel or composites with a 
polymer in the form of solution [3]. A typical wet electrospinning setup is shown in Figure 1. In 
general, ceramic nanofibres are produced by electrospinning ceramic precursors or nanoparticles along 
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with polymer followed by calcination at higher temperatures to remove polymer residues. However, 
there are also reports on the fabrication of ceramic nanofibres from ceramic sols in the absence  
of polymers [15–17]. 
Figure 1. A typical wet electrospinning setup. 
 
2.1. Alumina Nanofibres 
Alumina (Al2O3) is a bioinert ceramic with the characteristics of high abrasion resistance and 
chemical inertness. The biocompatibility of alumina has made it clinically reliable for more than  
30 years [18]. Al2O3, being used in both dental and orthopaedic applications, has shown increased 
osteoblast adhesion in nanofibre form compared to nanosphere and conventional alumina, with either 
nanometre- or micrometre-sized grains, which is promising as a potential substitute for bone tissue 
implants [19]. Azad et al. [20] fabricated transparent α-Al2O3 nanofibres of high structural quality by 
electrospinning composite sol made of high purity aluminium 2,4-pentanedionate and 
polyvinylpyrrolidone (PVP). The author performed the conceived temperature-time-heating rate 
profile calcination at 1000–1500 °C to understand the pathway of phase evolution in the ultimate 
ceramic product with the scope of the retention of the fibrillar artefacts. Raman studies of fired fibres 
were shown to be identical to those registered for commercial α-alumina powder with confirmation of 
the phase evolved to be α-alumina using a selected area electron diffraction (SAED) pattern.  
Panda et al. [21] reported electrospinning of Al2O3 nanofibres using aluminium acetate and aluminium 
nitrate in combination with polyvinyl alcohol (PVA) and polyethylene oxide (PEO). The authors 
demonstrated that electrospinning of both PVA and PEO was possible and was smooth in the case of 
the aluminium acetate precursor, whereas in the case of the aluminium nitrate precursor, the resulting 
nanofibres were reported to be highly hygroscopic, due to the presence of nitrate anions with difficulty 
in collection due to the strong repulsion. Through a similar approach, Tuttle et al. [22] fabricated and 
characterized Al2O3 nanofibres using boric acid-stabilized aluminium acetate and PVP. The authors 
measured a wide range of electrospinning conditions and characterization techniques to determine the 
types of bulk and surface characteristics that can be attained with these fibres after calcinations  
(Figure 2a,b). 
In contrast, Lamastra et al. [23] presented electrospinning of PVA solution containing dispersed 
alumina nanoparticles (20 nm average size). The authors used nanofiller content ranging between  
2 and 9 wt%, and the average fibre size was reported as 600 nm with Al2O3 nano- and/or  
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sub-micrometric agglomerates observed on and/or inside the PVA fibres. Yu et al. [24] examined the 
growth-related microstructures and the length-to-diameter ratio of single-crystal-type α-Al2O3 
electrospun nanofibres using HR-TEM. The author described that single-crystal α-Al2O3 nanofibres 
were found to form via the coalescence of well-elongated α-Al2O3 colonies growing in the (110) or 
(112) directions. The length-to-diameter ratio of each colony was reported to follow the 
thermodynamic requirement that exists with a size ratio limit for the length and diameter of each  
α-Al2O3 colony. Recently, Yu et al. [25] fabricated Al2O3 electrospun nanofibres from a novel solution 
containing water-insoluble polyacrylonitrile (PAN), non-aqueous N,N-dimethylformamide (DMF) and 
aluminium 2,4-pentanedionate, in which the mass ratio of aluminium to PAN of 1:1 was obtained. The 
author also reported that increasing the ceramic nanoparticle content decreased the crystallinity of 
fibres. With respect to hard tissue engineering applications, studies by Price et al. [19,26] revealed 
increased osteoblast function on nanofibre Al2O3 compared to other forms (Figure 2c) with possible 
explanations for such enhanced behaviour attributed to chemistry, the crystalline phase and 
topography, suggesting that it may be an ideal material for use in orthopaedic and dental applications. 
Figure 2. SEM images of (a) as-spun aluminium acetate/polyvinylpyrrolidone (PVP) 
fibres; (b) electrospun fibres after 1200 °C annealing [22] (reproduced with permission 
from Elsevier, Copyright 2006); and (c) osteoblast cell density under standard cell culture 
conditions determined on various alumina substrates. All data shown are the mean ± SEM 
(= 3). *p < 0.05 compared with all other material formulations; +p < 0.05 compared with 
conventional spherical alumina; **p < 0.05 compared with either reference material (glass 
and titanium) [26] (reproduced with permission from Wiley, Copyright 2003). 
 
2.2. Zirconia Nanofibres 
Zirconia (ZrO2), introduced in 1985 as an alternative material to alumina, is a bioinert bioceramic 
that has gained its application in total hip replacement for its high mechanical strength and fracture 
toughness [1]. Microscopic studies in animals have demonstrated that ZrO2 implants possess good 
biocompatibility and direct bone apposition to the implant [27]. Shao et al. [28] demonstrated the 
electrospinning of a sol comprising zirconia oxychloride and PVA followed by calcinations of the 
fibres at 800 °C. ZrO2 nanofibres with diameters of 50–200 nm were reported after calcinations [28]. 
Dharmaraj et al. [29] fabricated ZrO2 nanofibres of 200-nm diameter upon calcination of the zirconium 
oxide/poly(vinyl acetate) (PVAc) composite nanofibres prepared by sol-gel processing and 
electrospinning. The author demonstrated that calcination at 500 °C and 750 °C showed the presence 
of a tetragonal phase along with some traces of monoclinic zirconium oxide and calcination at  
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1000 °C with the monoclinic phase identified. In contrast, Lamastra et al. [23] demonstrated 
electrospinning of a solution comprising ZrO2 nanoparticle (20 nm average size) dispersed in PVA 
solution of 8 wt%. The average fibre size was reported as 600 nm with a homogeneous distribution of 
ZrO2 in polymer mats (Figure 3a). ZrO2 and zirconium nitride (ZrN)-coated biocompatible leads 
showing enhanced thrombogenicity, biocompatibility, blood compatibility and corrosion-resistance 
were patented earlier by Davidson et al. [30]. With ZrN shown to be biocompatible, Li et al. [31] 
successfully fabricated a ZrN nanofibre preparation by carbothermal reduction and nitridation of 
electrospun PVP/zirconium oxychloride composite fibres, whose fibre structure was kept by the 
connection of irregular fine particles, and the diameter of crystalline ZrN was reported in the range of 
100–500 nm (Figure 3b). Ahmad et al. [32] earlier showed that yttrium partially-stabilized zirconium 
dioxide posts as an approach to restoring coronally compromised non-vital teeth, and Azad et al. [33] 
reported the fabrication of phase pure yttria-stabilized zirconia nanofibres by electrospinning, 
investigating the structural and microstructural artefacts of the spun fibres. Recently, Li et al. [34] 
fabricated hollow fibres of yttria-stabilized zirconia (8YSZ) by calcination of electrospun composite 
fibres from sol comprised of zirconium oxychloride, yttrium nitrate and PVP, where the fibres were 
reported to be made of polycrystalline tetragonal phase ZrO2 (Figure 3c). 
Figure 3. SEM images of (a) electrospun PVA/ZrO2-H nanohybrid mats (inset:  
energy-dispersive X-ray spectrum) [23] (reproduced with permission from Elsevier, 
Copyright 2008); (b) ZrN fibres after heating treatment at 1600 °C [31] (reproduced  
with permission from Elsevier, Copyright 2008); and (c) 8YSZ hollow fibres calcined at 
1000 °C [34] (reproduced with permission from Elsevier, Copyright 2008). 
 
On the other hand, Kotha et al. [35] reported reinforcement of bone cements using ZrO2 fibres, 
supporting the potential applications of zirconia in orthopaedic applications. Li et al. [36] studied the 
phase transformation and morphological evolution of electrospun ZrO2 nanofibres during thermal 
annealing and reported that at different thermal cycles, the monoclinic-to-tetragonal transformation 
temperatures remained virtually unchanged, while the reverse transition temperatures systematically 
shifted from 924.9 to 978.6 °C with the progress of thermal cycles. Recently, Qin et al. [37] fabricated 
ZrO2 nanofibres with different morphologies, such as porous or compact fibres, in addition to the 
observed crystalline structure. Interestingly, Xu et al. [38] successfully demonstrated dense  
zirconia-yttria (ZY), zirconia-silica (ZS) and zirconia-yttria-silica (ZYS) nanofibres as reinforcing 
elements for dental composites. 
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2.3. Titania Nanofibres 
Titanium oxide (TiO2) and titanium alloys are superior to many biomedical materials, such as 
pyrolytic carbon, stainless steel, etc., for their mechanical properties and biocompatibility. TiO2 is a 
non-toxic, multi-faceted bioceramic, widely studied for its excellent biocompatibility [39,40].  
Lee et al. [41] reported TiO2/PVP nanocomposite nanofibres with average diameters of ~53 and  
~109 nm electrospun via a sol-gel prepared from Ti(IV)-isopropoxide (TiP) precursor (Figure 4a), 
whereas Son et al. [15] reported electrospinning of ultrafine TiO2 fibres in the absence of polymer 
additives with the formation of pure anatase titania fibres at low temperature. Interestingly,  
Son et al. [15] used nitric acid as the acid catalyst for the hydrolysis and polycondensation of TiP 
titanium. The surface of the TiO2 fibres in as-spun form was shown to be smooth and uniform, whereas 
the fibres obtained after calcination at 1300 °C were reported to have wavy surfaces [15].  
Lim et al. [42] successfully immobilized TiO2 nanofibres on titanium plates by electrospinning of sol 
comprising PVP and TiP for implant applications. On the other hand, Yuh et al. [43] reported barium 
titanate (BaTiO3) nanofibres via electrospinning, which was supposed to have other applications by 
that time (Figure 4b). BaTiO3 nanofibres with a perovskite structure were obtained after annealing at 
750 °C for 1 h, and the typical fibre morphology reported was 80–190 nm [43]. Later, Li et al. [44] 
reported the biocompatibility of BaTiO3 to have enhanced effects on the bioactivity of the nano-titania 
ceramics, which made the osteoblasts proliferate faster on the nano-titania ceramics in cell culture 
experiments. The author also suggested that this might be a potential way to prepare bioactive  
nano-TiO2 ceramics with biomechanical compatibility using BaTiO3 as a crystal growth inhibitor.  
With magnesium titanate identified to be osteo-inductive [45], Dharmaraj et al. [46] demonstrated 
phase pure magnesium titanate nanofibres of 200–400 nm in diameter with preparation at low 
temperatures for the first time by electrospinning sol-gel prepared from magnesium ethoxide, TiP and 
PVAc. On the other hand, Lee et al. [47] fabricated silicon dioxide (SiO2)/TiO2 composite fibres by 
sol-gel reaction and electrospinning. This silica-doped titania (SiO2/TiO2) was later reported to be 
biocompatible with potential implant applications [48]. Dharmaraj et al. [49] reported the preparation 
and characterization of nickel-titanate (NiTiO3) nanofibres with diameters in the range of 150–200 nm, 
for the first time using electrospun nickel titanate/PVAc composites as precursors and through 
calcination treatment. The author reported the crystalline phases present in the fibres after calcination 
treatment at different temperatures using X-ray diffraction analysis (XRD) (Figure 4c). The 
biocompatibility of NiTiO3 was later discussed by Bansiddhi et al. [50], accounting for its bioactivity 
in biomedical applications.  
In another context, Bahadur et al. [51] demonstrated the synthesis of hydroxyapatite crystals on 
electrospun TiO2 nanofibres. The authors verified the chemical treatment of TiO2 nanofibres by  
immersion in sodium hydroxide solution followed by calcination, HCl treatment and, finally, soaking 
in simulated body fluid (SBF) for various time intervals. These ceramic nanocomposite have special 
interest for biomedical applications, such as in dental and bone implants. Interestingly, a biological 
evaluation of the antimicrobial activity of electrospun Zn-doped titania nanofibres was performed by  
Anna et al. [52]. The authors reported the lowest concentration of Zn-doped titania nanofibre solution 
inhibiting the growth of S. aureus ATCC 29231 and E. coli ATCC 52922 strains to be 0.4 and  
1.6 μg/mL. A similar study was also performed by Hassan et al. [53], who reported the lowest 
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concentration of titania nanorod solution inhibiting the growth of a microbial strain with 5 μg/mL for a 
wide range of pathogens tested. Furthermore, the morphology and osteogenic potentials of TiO2-based 
electrospun nanofibres were recently studied by Wang et al. [54]. With TiO2 occurring in most 
common phases of anatase and rutile, Kiran et al. [55] recently studied the effects of the morphology 
and crystalline phase of electrospun TiO2 nanofibres on osteoblast cell response. Interestingly, the 
authors reported the rutile phase of electrospun TiO2 nanofibres to be relatively more favourable for 
osteoblast cell attachment and mineralization. 
Figure 4. TEM image of (a) TiO2 nanofibres [41] (reproduced with permission from 
Elsevier, Copyright 2005); and (b) BaTiO3 nanofibres (upper inset: high resolution image 
showing lattice fringes; lower inset: convergent beam electron diffraction pattern) [43] 
(reproduced with permission from Elsevier, Copyright 2005); (c) XRD patterns of NiTiO3 
fibres (label code a: as-prepared composite fibres; b: fibres calcined at 873 K; c: fibres 
calcined at 1073 K; d fibres calcined at 1173 K; and e fibres calcined at 1273 K) [49] 
(reproduced with permission from Elsevier, Copyright 2004). 
 
2.4. Pyrolytic Carbon Nanofibres 
Carbon exists in a variety of forms, including vitreous carbon and pyrolytic carbon. Intrinsic 
brittleness and low tensile strength limit its use in major load bearing applications. The key properties 
of pyrolytic carbon, such as biocompatibility, thrombo-resistant, good durability, wear resistance and 
strength, has made it applicable in the field of biomedical engineering [56]. Santiago-Aviles et al. [57] 
reported early electrospinning of polyacrylonitrile (PAN)-derived carbon fibres. The biocompatibility 
of filamentous carbon fibres was studied by Zimmerman et al. [58] and reported to be non-corrodible, 
bringing about no immunological response in vivo. In addition, pyrolytic carbon is also suited to small 
orthopaedic joints, such as fingers and spinal inserts. Zussman et al. [59] demonstrated electrospinning 
of PAN-derived carbon fibres and reported that the carbonized nanofibres showed the C atoms to be 
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partitioned into ~80% sp2 bonds and ~20% sp3 bonds, which agrees with the observed structural 
disorder in the fibres (Figure 5a). An electrospinning process using different PAN/DMF concentrations 
was demonstrated by Gomes et al. [60]. The authors demonstrated that the viscosity and applied 
voltage strongly affected the shape, length and morphology of the fibres. Kima et al. [61] 
demonstrated the ability to fabricate ultra-fine carbon fibres through electrospinning of the polymer 
blends of PAN and polyamic acid (PAA) with subsequent thermal treatment. Interestingly, the author 
derived a close correlation between the fibre diameter developed in the spinning process and the 
physical properties of the carbonized fibres; where the smaller diameter fibres were reported to give 
rise to the higher crystallinity of the single carbonized fibre and the mechanical strength of the 
carbonized fibre web. 
Figure 5. (a) SEM image of the fracture (during bath ultrasonication) surface of 
carbonized polyacrylonitrile (PAN) fibres [59] (reproduced with permission from Elsevier, 
Copyright 2005); (b) TEM image of nanocomposite fibrils showing a uniform distribution, 
no agglomeration and excellent SWNT alignment in a PAN fibre with a diameter of about 
50 nm [62] (reproduced with permission from Wiley, Copyright 2003); (c) SEM image of 
L929 mouse fibroblasts growing on an MWCNT-based network after seven days [63] 
(reproduced with permission from American Chemical Society, Copyright 2004). 
 
On the other hand, Ko et al. [62] demonstrated co-electrospinning of single-walled carbon nanotube 
(SWCNT)-filled nanofibre yarn (Figure 5b), whereas, Lam et al.  [64] demonstrated electrospinning of 
both SWCNT and multi-walled carbon nanotube (MWCNT)-filled nanofibres. With the 
biocompatibility of carbon nanotubes (CNTs) being questioned, Duarte et al. [63] demonstrated thin 
film networks of MWCNTs and their potential in biomedical applications by extensive growth, 
spreading and adhesion of the common mouse fibroblast cell line, L929, on them (Figure 5c). Further, 
Smart et al. [65] discussed the biocompatibility of carbon nanotubes, reporting that  
chemically-functionalized CNTs enhanced for drug delivery and have not demonstrated any toxicity. 
Moreover, Yeo et al. [66] has discussed the biocompatibility of various electrospun carbon nanotube 
polymer composites, as well as their characteristics and applications elsewhere. Zhang et al. [67] 
fabricated, by electrospinning, uniaxially-aligned carbon nanotube composite nanofibres with a 
diameter of ~100 nm using a collector consisting of two electrodes, as well as a slowly rotating drum. 
Wan et al. [68] successfully fabricated MWCNT-filled PAN fibres by electrospinning via both 
conventional and vibrational electrospinning. The authors reported that CNTs were aggregated heavily 
in the fibres obtained by traditional electrospinning, while CNTs were well distributed and aligned in 
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PAN fibres obtained by vibration-electrospinning. A whole new class of bioactive carbon nanofibres 
has been created for biological applications, and the applications in regenerative medicine are 
reviewed elsewhere [69,70]. Recently, Volpato et al. [71] studied the tuneable morphological and 
mechanical properties of electrospun nanofibres composed of aligned fibres of polyamide 6 (PA6) and 
carboxyl-functionalized MWCNT. The authors reported that the proliferation and activation of 
microglial MG63 osteoblast cell lines were enhanced due to surface modification caused by the filler 
addition compared to the pristine PA6 networks. 
2.5. Calcium Phosphate Ceramic Nanofibres 
It has been known for years that calcium phosphate ceramics are used for bone tissue augmenting 
and replacement. There are several calcium phosphate ceramics that are considered to be 
biocompatible, including α-tricalcium phosphate (α-TCP), β-tricalcium phosphate (β-TCP), 
tetracalcium phosphate (Ca4P2O9) and hydroxyapatite (HAp) (Ca10(PO4)6(OH)2), of which HAp is the 
most widely studied bioceramic, as it is thermodynamically stable at physiological pH and actively 
takes part in bone bonding. The Ca/P ratio of HAp is 1.67 equivalents to that of bone and is stable in 
body fluids [2]. Ito et al. [72] reported solution-mediated mineralization of HAp on biodegradable 
polymer nanofibres where the surface mineralization of HAp contributed to the bioactivity of the 
polymer fibre mats. Venugopal et al. [73] demonstrated nano-HAp (nHAp) powder-dispersed 
biodegradable collagen-polycaprolactone composite polymers (PCL/nHAp/Col) of a diameter ranging 
from 60 to 600 nm by electrospinning. The authors reported that PCL provided mechanical stability, 
collagen-supported cell proliferation and nHAp for the mineralization of osteoblasts for bone 
regeneration. Mei et al. [74] reported electrospinning of nHAp sol prepared from triethyl phosphite 
precursor and PVP as a polymer component. On the other hand, Li et al. [75] demonstrated conjugate 
electrospinning of poly(L-lactide)(PLLA)/nano-β-TCP composite nanofibres, where the authors used 
two spinnerets with opposite polarity. The effect of the process and solution parameters on the fibre 
morphology were demonstrated, and the nanofibres were reported to have a rough surface, which is 
attributed to the dispersion of TCP nanoparticles on the surface of the composite nanofibres [75].  
Interestingly, Erisken et al. [76] fabricated functionally-graded electrospun polycaprolactone and  
β-TCP nanocomposites for tissue engineering applications by hybrid twin-screw 
extrusion/electrospinning carried out for spinning fibres of a diameter ranging from 200–2000 nm. 
Teng et al. [77] demonstrated 30 wt% collagen-HAp composite sol preparation by a modified 
procedure followed by electrospinning of the sol, where the modified procedure demonstrated a higher 
efficiency in preparing uniform inorganic/organic composite nanofibres than the conventional method  
(Figure 6a). Similarly, Guan et al. [78] reported electrospinning of poly(3-hydroxybutyrate)  
(PHB)-based fibrous scaffolds containing 10 wt% nHAp that exhibited much better support for the 
attachment, proliferation and differentiation of rat bone marrow stromal cells (BMSCs) than pure PHB 
scaffolds. It was also reported that, compared with the pure PHB fibres, which were smooth and 
uniform, the surfaces of the nHAp/PHB composite fibres were rougher, as nHAp nanoparticle 
protruded from the surface layer of the composite fibres. Zhang et al. [79] presented a two-step 
approach combining the in situ co-precipitation synthesis route with the electrospinning process to 
prepare a novel type of biomimetic nanocomposite nanofibres of HAp/chitosan. The author 
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demonstrated that the incorporation of HAp nanoparticles into chitosan (CTS) nanofibrous scaffolds 
led to significant bone formation-oriented outcomes compared to that of the pure electrospun CTS 
scaffolds. On the contrary, Liao et al. [80] and Yang et al. [81] demonstrated solution-mediated 
mineralization of nHAp on biodegradable polymer nanofibres, such as collagen,  
poly(lactic-co-glycolic acid) (PLGA) and PCL (Figure 6b). The authors reported that the surface 
mineralization of HAp contributes to the bioactivity of the polymer fibre mats with a decrease in the 
contact angle (Figure 6c). 
Figure 6. (a) TEM image of the collagen-30 wt% HAp composite fibres at  
high magnifications. The inset shows the selected area diffraction (SAD) pattern of the 
fibres [77] (reproduced with permission from Elsevier, Copyright 2008); (b) SEM 
micrograph showing the surface of the electrospun polycaprolactone (PCL) scaffolds after 
coating with simulated body fluid (SBF; 10×) for 2 h; and (c) contact angle measurements 
on a pristine electrospun PCL mat and electrospun PCL scaffolds after coating with SBF10 
for 2 h [81] (reproduced with permission from Elsevier, Copyright 2008); (d) single-phase 
hydroxyapatite (HAp) fabrics (film and tube) prepared by calcination of HAp/PVP 
composite nanofibres as the precursor [82] (reproduced with permission from Elsevier, 
Copyright 2010). 




Interestingly, Yu et al. [83] showed the mineralization of nanocrystalline apatite on  
poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) through a series of solution-mediated 
biomimetic processes on the surface of PCL nanofibre scaffolds. The surface-mineralized PCL 
nanofibres were demonstrated to support the adhesion and growth of rat bone-marrow stromal cells 
(rBMSCs) and to stimulate their differentiation into an osteogenic lineage, showing a potential matrix 
for skeletal tissue regeneration [83]. Jose et al. [84] fabricated aligned PLGA/HAp nanofibrous 
composite scaffolds by electrospinning and demonstrated in vivo biodegradation of the electrospun 
scaffolds. Biansco et al. [85] demonstrated electrospinning of calcium-deficient nHAp with PCL 
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followed by mechanical characterization and biocompatibility using mouse fibroblast. Recently,  
Chen et al. [82] demonstrated sintered HAp nanofibres (Figure 6d) from nanoparticles by an 
electrospinning system comprising nHAp particles and PVP. The fibres were calcined to 600 °C for  
6 h to get a continuous fibre structure shown to be biocompatible with mesenchymal stem cells by 
electron microscopy. However, the mechanical properties of HAp have been reported to be unsuitable 
for load-bearing applications, such as orthopaedics; therefore, it is mostly used as a coating on 
materials, such as titanium and titanium alloy nanofibres, where it can contribute its ‘bioactive’ 
properties, while the metallic component bears the load [82]. Fascinatingly, Wei et al. [86] reported a 
promising novel bone tissue engineering biocomposite scaffold material made of electrospun silk 
fibroin/nHAp by means of an effective calcium and phosphate (Ca-P) alternate soaking method within 
several minutes without any pre-treatment. With the osteoblastic-like cell line MC3T3-E1 (derived 
from Mus musculus (mouse) calvaria) functionalities, such as alkaline phosphatase (ALP) activity, 
shown to ameliorate mineralized nanofibre, the silk/nHA biocomposite scaffold material could be a 
promising biomaterial for bone tissue engineering [86]. Very recently, Song et al. [87] demonstrated 
tuned morphological electrospun HAp nanofibres by electrospinning and sol-gel showing that HAp 
nanofibres are even and well-crystallized, and the pH is crucial for producing HAp nanofibres. The 
authors reported that with the change of pH from 4 to 9, nanofibres grow densely along the (210) plane 
and become compact, while the surface area, pore volume and pore size decrease correspondingly. 
2.6. Bioactive Glass Nanofibres 
Bioactive glasses are a group of surface-reactive biocompatible glass-ceramics first developed by 
Larry Hench and colleagues at the University of Florida in the late 1960s [88]. Kim et al. [89] reported 
the first electrospinning of bioactive glass nanofibres with variable diameters using a sol-gel precursor 
of the composition 70SiO2·25CaO·5P2O5 prepared under appropriate conditions (Figure 7a). The 
authors reported that the nanofibres demonstrated excellent bioactivity and osteogenic potential  
in vitro by a bioactivity test and cellular response assay. Furthermore the authors developed a novel 
nanocomposite biomaterial consisting of bioactive glass nanofibre (BGNF) and collagen for bone 
regenerative medicine from a sol-gel with a bioactive composition (58SiO2·38CaO·4P2O5) by 
electrospinning (Figure 7b) [90]. The average fibre diameter was reported to be ~320 nm, and the 
nanocomposite exhibited an active induction of apatite minerals on its surface under simulated body 
fluid conditions, showing excellent bioactivity in vitro. Further, the authors also demonstrated the 
bioactivity and osteoblast responses of a novel biomedical nanocomposite of bioactive glass 
(58SiO2·38CaO·4P2O5) nanofibre-filled poly(lactic acid). The electrospun nanofibre reported had a 
diameter of 320 nm on average and subsequently was combined with PLA solution under adjusted 
processing conditions. The reported nanofibre-PLA exhibited a typical nanocomposite structure, 
wherein the glass nanofibres were uniformly dispersed in the PLA matrix [91]. Lee et al. [92] 
demonstrated improved bioactivity of PCL membrane electrospun with the addition of nanofibrous 
bioactive glass (70SiO2·25CaO·5P2O5). The bioactivity and osteoblastic responses of the 
nanocomposite membrane was reported with a higher level of growth than on the pure PCL membrane. 
Yi et al. [93] effectively prepared sol-gel-derived mesoporous bioactive glass (80SiO2·15CaO·5P2O5) 
fibres as tissue-engineering scaffolds by electrospinning. The authors fabricated a three-dimensional 
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(3D) macro-structure with a ~50–100 µm interconnected macroporous structure by electrospinning, 
and the fibres were reported to possess a well-ordered hexagonal mesostructure with excellent in vitro 
bioactivity. Lu et al. [94] demonstrated submicron bioactive glass (70SiO2·30CaO) fibres for a bone 
tissue scaffold by electrospinning. The diameters of the submicron fibres were reported in the range of 
50–800 nm, and the hardness and elastic modulus of the fibres were measured by nano-indentation to 
be 0.21 and 5.5 GPa, respectively [94]. Allo et al. [95] fabricated composite nanofibres of PCL and 
tertiary bioactive glass (with a glass composition of 70 mol% SiO2, 26 mol% CaO and 4 mol% of 
P2O5) by electrospinning. 
Figure 7. (a) TEM images of bioactive glass nanofibre after incubation in a simulated 
body fluid for three days [89] (reproduced with permission from Wiley, Copyright 2006); 
(b) TEM image of the bioactive glass nanofibre (BGNF)-Col nanocomposite, showing the 
mesoporous BGNF nanofibres (300–400 nm in diameter) organized with collagen  
self-assembled nano-fibrils (less than 100 nm in diameter) [90] (reproduced with 
permission from Wiley, Copyright 2006); and (c) fluorescence microscopy images 
showing the osteoblast precursor cell (MC3T3-E1) morphology after culturing for three 
days on electrospun bioactive glass fibres [96] (reproduced with permission from Elsevier, 
Copyright 2012). 
 
Boccaccini et al. [97] discussed the physico-chemical, mechanical and biological advantages of 
incorporating nanoscale bioactive glass in biodegradable nanocomposites and the possibilities to 
expand the use of these materials in other nanotechnology concepts aimed for use in different 
biomedical applications. Furthermore, Rahman et al. [98] assessed bioactive glasses in tissue 
engineering, reporting bioactive glass to have a unique set of properties, such as converting to an  
HA-like material, to bond firmly to hard and soft tissues and to release ions during the degradation 
process. These ions are also reported to have a beneficial effect on osteogenesis and on angiogenesis, 
which may also have a beneficial effect on chondrogenesis [98]. Interestingly, Xie et al. [96] 
fabricated submicron bioactive glass tubes using sol-gel and coaxial electrospinning techniques for 
applications in bone tissue engineering. The author also demonstrated that the proliferation rate of 
mouse preosteoblastic MC3T3-E1 cells on bioactive glass tubes (Figure 7c) was comparable to that on 
solid fibres, and the bioactive glass tubes can be loaded with a model protein drug, bovine serum 
albumin, where these structures exhibit delayed release properties. Recently, Huang et al. [99] 
fabricated luminescent Eu3+/Tb3+-doped mesoporous bioactive glass nanofibres (MBGNFs) with an 
average diameter of 100–120 nm by the electrospinning method. The author reported that the 
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biocompatibility tests conducted with L929 fibroblast cells using the MTT assay revealed the low 
cytotoxicity of the generated nanofibres, whereas the luminescent nanofibres showed sustained release 
properties for ibuprofen (IBU) in vitro, and the emission intensities of Eu3+ in the drug delivery system 
varied with the released amount of IBU. 
3. Conclusion and Future Perspective 
Electrospinning is a simple and adaptable technique for high functional nanofibre production, which 
can amend the world of structural and functional materials. The advantages of the electrospinning 
technique, including the production of very thin fibres with a large surface area, aspect ratio, superior 
mechanical properties and ease of functionalization for various purposes, provide a wide range of 
opportunities for their application in tissue engineering, drug delivery, etc. Recently, composite 
electrospinning of nHAp-bioglass [100,101], PAN-bioglass [102,103] hybrids and ceramic-based 
composites containing new bioceramics, such as willemite (Zn2SiO4) [104], dicalcium phosphate 
anhydrate (DCPA) [105], dicalcium silicate (C2S) [106], etc., has demonstrated these as potential 
candidates for bone tissue regeneration, showing the advancements in the field. 
Synthetic HAp, being extensively used in hard tissue regeneration, like bone, can be potentially 
substituted or replaced by HAp derived from natural sources, like eggshell, corals, etc. [107,108], 
which could mimic ions close to that of natural bone, leading to better biocompatibility and tissue 
interactions. Furthermore, the use of CNT to reinforce and enhance the performance of the composite 
can produce a new generation of nanocomposite materials, where the critical issues of CNT 
embedment in nanocomposites during processing have to be studied in detail. Moreover, the surface 
modification of electrospun scaffolds with suitable bioactive agents could be an effective means to 
fine-tune the functionality of nanofibres for specific biomedical applications. 
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